Skip to Main Content

Paper Details

Three-year Outcomes After Conversion From Monthly to Every 2-month Belatacept Maintenance Therapy in Kidney Transplant Recipients: Results From a Randomized Controlled Trial.
Transplant Direct
1
2023
Author NameAffiliation
Kirk A EasleyRollins School of Public Health, Emory University
  • 1 - 1

Datasets

Release 1.2